| Monday, November 2, 2009 | ||
| 12:00:00 | New Presentation | |
| 12:30:00 | Registration | |
| 14:00:00 | Chairperson’s Opening Remarks | Cristina Rondinone |
| 14:10:00 | Delivery is in the Details | Catherine J. Pachuk |
| 14:35:00 | Challenges in RNAi Delivery | |
| 14:40:00 | Stem Cells as a Non-Immunogenic Vehicle for Delivery of siRNA | Peter R. Brink |
| 15:10:00 | Nanoparticles for Controlled and Targeted Delivery of siRNA | Mark Saltzman |
| 15:40:00 | Networking Refreshment Break in the Exhibit Hall | |
| 16:20:00 | A Biodegradable, Biocompatible, Sustained Release System for RNAi Delivery | Seth D. Feuerstein |
| 16:50:00 | Highly Efficient Delivery of RNAi to Neurons in Vivo Using NeuroVex | Anna-Maria Anesti, Suzanne Thomas |
| 17:20:00 | Cell Type-specific siRNA Delivery and the Treatment of Disease | Derek M. Dykxhoorn |
| 17:50:00 | Combinatorial Development of Synthetic siRNA Delivery Systems | Daniel G Anderson |
| 18:20:00 | Close of Day | |
| Tuesday, November 3, 2009 | ||
| 07:30:00 | Continental Breakfast Breakout Discussions | |
| 07:35:00 | CHALLENGES IN THE CLINIC | |
| 08:35:00 | Chairperson’s Remarks | Bob D. Brown |
| 08:40:00 | Reversal of Drug Resistance in Cancer: Dual Sequential Treatment with Targeted si/shRNA and Drug Packaged Nanocells | Himanshu Brahmbhatt |
| 09:10:00 | Title to be Announced | Elena Feinstein |
| 09:40:00 | Title to be Announced | Klaus Giese |
| 10:10:00 | Networking Coffee Break in the Exhibit Hall | |
| 10:55:00 | Development of Novel RNAi Therapeutic Compounds and In Vivo Delivery Approaches | Dmitry Samarsky |
| 11:25:00 | RNAi: Developing A New Therapeutic Platform Keynote Presentation | John M. Maraganore |
| 11:55:00 | Panel Discussion: Addressing the Clinical Challenges Associated with RNAi Therapeutics | |
| 12:25:00 | Luncheon Presentation (Sponsorship Opportunity Available) or Lunch on Your Own | |
| 12:30:00 | NEW FORMULATIONS AND GENE SILENCING OPTIONS | |
| 13:55:00 | Chairperson’s Remarks | Dmitry Samarsky |
| 14:00:00 | siRNA Construct and Delivery for Effective RNAi | Michael V. Templin |
| 14:30:00 | Novel Cationic Liposome Formulation for RNAi-based Validation of Therapeutic Targets in Rheumatoid Arthritis | Florence Apparailly |
| 15:00:00 | Networking Ice Cream Refreshment Break in Exhibit Hall (Last Chance for Viewing) | |
| 15:40:00 | siRNA-Based Topical Microbicides Targeting Sexually Transmitted Diseases | Deborah Palliser |
| 16:10:00 | Nuclear Gene Silencing with U1 Adaptor Oligonucleotides | Sam Gunderson |
| 16:40:00 | Locked Nucleic Acid-based Oligonucleotides (LNA-ONs) as RNA Antagonists for the Control of Cancer | Lee Greenberger |
| 17:10:00 | Close of Conference | |
| 17:20:00 | Announcements | |
How We Rank